Andera Partners, Ally Bridge Group, Longitude Capital and Omega Funds led a $196m round in Kestra Medical Technologies.

Andera Partners, an investment company, Ally Bridge Group, a healthcare-focused investment group, Longitude Capital, a healthcare venture capital firm, and Omega Funds, an investment firm, led a $196m round in Kestra Medical Technologies, a provider of cardiac monitoring and therapy solutions, with participation from Bain Capital and Endeavour Vision. “We are impressed with the clinical performance of the Kestra technology, their patient-focused approach and moreover, the exciting opportunity to penetrate this large and growing patient population. We are keen to partner with Kestra and their passionate team as they work to disrupt the existing $1bn WCD market,” Aneta Sottil, Andera Partners Partner.